Stay updated on InMed Pharmaceuticals Press Releases

Sign up to get notified when there's something new on the InMed Pharmaceuticals Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the InMed Pharmaceuticals Press Releases page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    InMed Pharmaceuticals has strengthened its patent portfolio with the issuance of three U.S. patents, while the previous report on its fiscal 2023 financial results has been removed.
    Difference
    6%
    Check dated 2024-08-28T02:24:59.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    InMed Pharmaceuticals has introduced a new oral formulation, INM-901, targeting Alzheimer's Disease, while also updating their address to 885 West Georgia St., Vancouver.
    Difference
    9%
    Check dated 2024-08-21T00:15:33.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    30 days ago
    No Change Detected
  6. Check
    37 days ago
    Change Detected
    Summary
    InMed Pharmaceuticals has announced favorable behavioral outcomes with INM-901 in a long-term preclinical Alzheimer's disease study, confirming previous short-term pilot study data, while a previous announcement about their presentation at the H.C. Wainwright conference has been removed.
    Difference
    7%
    Check dated 2024-07-30T22:12:35.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The values for Epidermolysis Bullosa and Glaucoma have swapped positions with the values for Alzheimer’s Disease and Age-related Macular Degeneration in the recent update on the webpage.
    Difference
    4%
    Check dated 2024-06-21T05:38:49.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    The webpage now shows that InMed will be presenting at the Emerging Growth Conference on June 10, 2024, instead of participating in a Fireside Chat with Water Tower Research on July 25, 2023. This indicates a shift in upcoming events and engagements for InMed Pharmaceuticals.
    Difference
    7%
    Check dated 2024-06-11T22:12:45.000Z thumbnail image
  9. Check
    113 days ago
    Change Detected
    Summary
    The webpage content has been updated from 'InMed Provides Update on BayMedica Rare Cannabinoid Business July 20, 2023' to 'InMed Pharmaceuticals Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update May 14, 2024'. This change likely represents a recent financial report or business update announcement by InMed Pharmaceuticals.
    Difference
    6%
    Check dated 2024-05-15T02:59:53.000Z thumbnail image

Stay in the know with updates to InMed Pharmaceuticals Press Releases

Enter your email address, and we'll notify you when there's something new on the InMed Pharmaceuticals Press Releases page.